Article
The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use.
Japanese journal of clinical oncology - 1 Nov 2012
Koh Youngil, Lee Hee Eun, Oh Do-Youn, Kim Jee Hyun, Lee Se-Hoon, Kim Se Hyung, Kim Dong-Wan, Im Seock-Ah, Kim Tae-You, Heo Dae Seog, Kim Woo-Ho, Bang Yung-Jue
Abstract excerpt
OBJECTIVE: We evaluated the characteristics of the gastrointestinal stromal tumors that showed discrepancies between their assessment using the Response Evaluation Criteria in Solid Tumor (RECIST) and Choi's criteria. We also investigated the clinical applicability of Choi's criteria to Korean gastrointestinal stromal tumor patients undergoing imatinib therapy. METHODS: Patients with advanced gastrointestinal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
